Source: FinanzNachrichten

Innate Pharma: Innate Pharma SA: Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") will hold its annual general meeting of shareholders ("AGM") at 10:30 a.m. CEST on May 22, 2025 in...

Read full article »
Annual Revenue
$25-100M
Employees
100-250
Jonathan Dickinson's photo - Chairman & CEO of Innate Pharma

Chairman & CEO

Jonathan Dickinson

CEO Approval Rating

82/100

Read more